- Section 1 ICU organization and management
- Section 2 Pharmacotherapeutics
- Section 3 Resuscitation
- Section 4 The respiratory system
- Section 5 The cardiovascular system
- Section 6 The gastrointestinal system
- Section 7 Nutrition
- Section 8 The renal system
- Section 9 The neurological system
- Part 9.1 Anatomy and physiology
- Part 9.2 Neurological monitoring
- Part 9.3 Sleep disturbance
- Part 9.4 Agitation, confusion, and delirium
- Part 9.5 The unconscious patient
- Part 9.6 Seizures
- Part 9.7 Intracranial hypertension
- Part 9.8 Stroke
- Chapter 234 Epidemiology of stroke
- Chapter 235 Diagnosis and assessment of stroke
- Chapter 236 Management of ischaemic stroke
- Chapter 237 Management of parenchymal haemorrhage
- Part 9.9 Non-traumatic subarachnoid haemorrhage
- Part 9.10 Meningitis and encephalitis
- Part 9.11 Non-traumatic spinal injury
- Part 9.12 Neuromuscular syndromes
- Section 10 The metabolic and endocrine systems
- Section 11 The haematological system
- Section 12 The skin and connective tissue
- Section 13 Infection
- Section 14 Inflammation
- Section 15 Poisoning
- Section 16 Trauma
- Section 17 Physical disorders
- Section 18 Pain and sedation
- Section 19 General surgical and obstetric intensive care
- Section 20 Specialized intensive care
- Section 21 Recovery from critical illness
- Section 22 End-of-life care
(p. 1121) Management of parenchymal haemorrhage
- Chapter:
- (p. 1121) Management of parenchymal haemorrhage
- Author(s):
Candice Delcourt
and Craig Anderson
- DOI:
- 10.1093/med/9780199600830.003.0237
Parenchymal intracerebral haemorrhage (ICH) affects several million people in the world each year, most of whom reside in developing countries. ICH accounts for 10-40% of strokes and is the least treatable form of stroke with a 30-day mortality of 30-55%, with half of these deaths occurring within the first few days of onset. . High blood pressure is both a causal and prognostic factor for ICH, with early control of hypertension being the only medical treatment which may improve recovery and the level of residual functioning. The role of surgery remains controversial. Management is largely supportive and aimed at reducing further brain injury and preventing complications.
Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.
Please subscribe or login to access full text content.
If you have purchased a print title that contains an access token, please see the token for information about how to register your code.
For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.
- Section 1 ICU organization and management
- Section 2 Pharmacotherapeutics
- Section 3 Resuscitation
- Section 4 The respiratory system
- Section 5 The cardiovascular system
- Section 6 The gastrointestinal system
- Section 7 Nutrition
- Section 8 The renal system
- Section 9 The neurological system
- Part 9.1 Anatomy and physiology
- Part 9.2 Neurological monitoring
- Part 9.3 Sleep disturbance
- Part 9.4 Agitation, confusion, and delirium
- Part 9.5 The unconscious patient
- Part 9.6 Seizures
- Part 9.7 Intracranial hypertension
- Part 9.8 Stroke
- Chapter 234 Epidemiology of stroke
- Chapter 235 Diagnosis and assessment of stroke
- Chapter 236 Management of ischaemic stroke
- Chapter 237 Management of parenchymal haemorrhage
- Part 9.9 Non-traumatic subarachnoid haemorrhage
- Part 9.10 Meningitis and encephalitis
- Part 9.11 Non-traumatic spinal injury
- Part 9.12 Neuromuscular syndromes
- Section 10 The metabolic and endocrine systems
- Section 11 The haematological system
- Section 12 The skin and connective tissue
- Section 13 Infection
- Section 14 Inflammation
- Section 15 Poisoning
- Section 16 Trauma
- Section 17 Physical disorders
- Section 18 Pain and sedation
- Section 19 General surgical and obstetric intensive care
- Section 20 Specialized intensive care
- Section 21 Recovery from critical illness
- Section 22 End-of-life care